TuHURA Biosciences, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
63.7M
on 2026-06-30, from 42.3M on 2024-12-31 10-Q ↗
Counts before 2024-12-31 are left out: the count went from 55.30B on 2024-05-13 to 42.3M on 2024-12-31, a change no split on file explains.
a raise that quarter, at its price
$50.0M
H.C. Wainwright, agreement of 2025-11-04. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗
Warrants
32.29M
Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $3.00. 10-Q ↗
Cash
0.1 quarters
$996K on 2026-06-30 ÷ $7.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-12-09 | Public offering with warrants at $1.95 | 9,462,423 | $1.65 | $15.6M | 424B5 ↗ |
| 2025-12-09 | Registered direct offering | 9,462,423 | not read | $8.6M | 8-K ↗ |
Also on file: $3.0M promissory notes, 2025-02-12 8-K ↗ · up to $3.0M promissory note agreed 2025-10-27 8-K ↗ · up to $3.0M promissory note agreed 2025-12-02 8-K ↗